IS THERE TREATMENT EFFECT OF VINPOCETINE ON AUTONOMIC DYSFUNCTION IN RATS WITH ALZHEIMER
Journal Title: Asian Journal of Pharamceutical and Clinical Research - Year 2017, Vol 10, Issue 2
Abstract
Alzheimer's disease (AD) shows less autonomic dysfunction. There was lack of response or prolongation of its latency in skin sympathetic response. Vinpocetine is a classic inhibitor of PDE1 activity. Vinpocetine treatment has been shown to enhance performance on cognitive tests in humans. The efficacy of the use of vinpocetine in clinical trials has been controversial. A comparison of multiple studies evaluating vinpocetine use in Alzheimer's disease AD was recently conducted. Objective: Our first aim was to assess dysautonomia in rat with Alzheimer's disease AD electrophysiologically, using sympathetic skin response (SSR) test. The second aim in this study, evaluate of the effect of vinpocetine treatment on Alzheimer autonomic dysfunction and attention deficiency.Method: Rats were divided into four groups: Sham group (Group C, i.p. saline), Alzheimer group (Group A), Vinpocetine group (Group V, 5mg/kg, every other day, i.p.), Alzheimer+ Vinpocetine group (Group AV). Alzheimer's disease was induced in old male rats by AlCl3 (40 mg/kg i.p.) and D-Galactose (90 mg/kg) daily for 6 weeks. Then Skin Conductance Level (SCL), which is a sympathetic skin response parameter, was measured as tonic (no-stimuli period, 2 min) and phasic SSR (simultaneously with 15 auditory stimuli, 10 min). Tonic SSR is useful to investigate general states of arousal and alertness, while phasic SSR is useful to study multifaceted attentional processes (related to novelty, intensity). Results: SCL was difference among groups (tonic: F=21.47, p≤0.000; phasic: F=9.86, p≤0.000). Skin conductance level (SCL) was statistically lower in Group A than Group C (p≤0.005) and Group V (p≤0.000). SCL of Group V was statistically higher then Group C (p≤0.04), Group A (p≤0.000) and Group AV (p≤0.000). SCL of Group AV was lower than Group C’s (p≤0.01). Conclusion: There were no statistically difference between Group A and Group AV. We concluded that autonomic disturbances accompanied Alzheimer's disease and vinpocetine treatment couldn’t ameliorate this disturbance. Keywords: Autonomic dysfunction, Dysautonomia, Inhibitor, Skin conductance level, Sympathetic skin response Â
Authors and Affiliations
Azizuddin Khan, Nazan Dolu, Seda Gündüz, Ali Yucel Kara, Hale Acer, Selda Tasa
Keywords
Related Articles
- EP ID EP605406
- DOI 10.22159/ajpcr.2017.v10i2.11367
- Views 111
- Downloads 0
ANTI-ATHEROSCLEROTIC ACTIVITY OF ELAEOCARPUS GANITRUS ROXB. IN CHOLESTEROL-FED RABBITS
  Objectives: Atherosclerosis was experimentally induced in New Zealand white male rabbits by cholesterol feeding for 120 days for investigating effects of 70% ethanolic Elaeocarpus ganitrus seed extract (EEGS) against...
ANTI-ULCER ACTIVITY OF HYDROALCOHOLIC EXTRACT OF PIPER BETLE LEAF ON EXPERIMENTAL ANIMALS
Objective: The main objective of this study is to establish the anti-ulcer activity of hydroalcoholic extract of Piper betle leaf on experimental animals based on previously existing aspects such as antioxidant, antihist...
FORMULATION AND EVALUATION OF NOVEL IN SITU GEL OF LAFUTIDINE FOR GASTRO RETENTIVE DRUG DELIVERY
Objective: The aim of the present study was to formulate and evaluate the novel in situ gel of lafutidine for gastroretentive drug deliveryMethods: A gastroretentive in situ gel of lafutidine was formulated by pH-trigger...
DARAPLADIB INHIBIT ADHESION MOLECULE EXPRESSION IN AORTA AT EARLY STAGES OF ATHEROSCLEROSIS USING SPRAGUE-DAWLEY TYPE 2 DIABETES MELLITUS MODEL
Objective: Hyperglycemia and hyperlipidemia in diabetes mellitus (DM) can lead an atherosclerosis. The increase of low-density lipoprotein level in DM and atherosclerosis is correlated with lipoprotein-associated phospho...
FORMULATION, IN VITRO AND EX VIVO CHARACTERIZATION OF MUCOADHESIVE BUCCAL TABLETS FOR ANTIHYPERTENSIVE DRUG
Objective: Olmesartan belongs to a class of angiotensin II receptor blockers. It is used in the treatment of hypertension. However, it undergoes extensive hepatic first-pass metabolism, resulting in low oral bioavailabil...